247 related articles for article (PubMed ID: 34788382)
1. PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia.
Goswami S; Mani R; Nunes J; Chiang CL; Zapolnik K; Hu E; Frissora F; Mo X; Walker LA; Yan P; Bundschuh R; Beaver L; Devine R; Tsai YT; Ventura A; Xie Z; Chen M; Lapalombella R; Walker A; Mims A; Larkin K; Grieselhuber N; Bennett C; Phelps M; Hertlein E; Behbehani G; Vasu S; Byrd JC; Muthusamy N
Blood; 2022 Mar; 139(9):1340-1358. PubMed ID: 34788382
[TBL] [Abstract][Full Text] [Related]
2. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
[TBL] [Abstract][Full Text] [Related]
3. The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias.
Pippa R; Odero MD
Cells; 2020 Feb; 9(3):. PubMed ID: 32110991
[TBL] [Abstract][Full Text] [Related]
4. c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia.
Su R; Gong JN; Chen MT; Song L; Shen C; Zhang XH; Yin XL; Ning HM; Liu B; Wang F; Ma YN; Zhao HL; Yu J; Zhang JW
Oncotarget; 2016 Nov; 7(47):77430-77443. PubMed ID: 27764807
[TBL] [Abstract][Full Text] [Related]
5. PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect.
Cristóbal I; Garcia-Orti L; Cirauqui C; Alonso MM; Calasanz MJ; Odero MD
Leukemia; 2011 Apr; 25(4):606-14. PubMed ID: 21233840
[TBL] [Abstract][Full Text] [Related]
6. The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells.
Ruvolo PP; Ruvolo VR; Jacamo R; Burks JK; Zeng Z; Duvvuri SR; Zhou L; Qiu Y; Coombes KR; Zhang N; Yoo SY; Pan R; Hail N; Konopleva M; Calin G; Kornblau SM; Andreeff M
Biochim Biophys Acta; 2014 Sep; 1843(9):1969-77. PubMed ID: 24858343
[TBL] [Abstract][Full Text] [Related]
7. Novel B55α-PP2A mutations in AML promote AKT T308 phosphorylation and sensitivity to AKT inhibitor-induced growth arrest.
Shouse G; de Necochea-Campion R; Mirshahidi S; Liu X; Chen CS
Oncotarget; 2016 Sep; 7(38):61081-61092. PubMed ID: 27531894
[TBL] [Abstract][Full Text] [Related]
8. c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations.
Luo H; Li Q; O'Neal J; Kreisel F; Le Beau MM; Tomasson MH
Blood; 2005 Oct; 106(7):2452-61. PubMed ID: 15972450
[TBL] [Abstract][Full Text] [Related]
9. p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia.
Zhang J; Seet CS; Sun C; Li J; You D; Volk A; Breslin P; Li X; Wei W; Qian Z; Zeleznik-Le NJ; Zhang Z; Zhang J
Mol Oncol; 2013 Dec; 7(6):1069-82. PubMed ID: 23988911
[TBL] [Abstract][Full Text] [Related]
10. Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression.
Zhang L; Zhou H; Li X; Vartuli RL; Rowse M; Xing Y; Rudra P; Ghosh D; Zhao R; Ford HL
Nat Commun; 2018 Mar; 9(1):1047. PubMed ID: 29535359
[TBL] [Abstract][Full Text] [Related]
11. The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells.
Salvatori B; Iosue I; Mangiavacchi A; Loddo G; Padula F; Chiaretti S; Peragine N; Bozzoni I; Fazi F; Fatica A
Cell Death Dis; 2012 Oct; 3(10):e413. PubMed ID: 23096114
[TBL] [Abstract][Full Text] [Related]
12. Regulation of p21 by TWIST2 contributes to its tumor-suppressor function in human acute myeloid leukemia.
Zhang X; Ma W; Cui J; Yao H; Zhou H; Ge Y; Xiao L; Hu X; Liu BH; Yang J; Li YY; Chen S; Eaves CJ; Wu D; Zhao Y
Oncogene; 2015 Jun; 34(23):3000-10. PubMed ID: 25088197
[TBL] [Abstract][Full Text] [Related]
13. l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)
Song JH; Park E; Kim MS; Cho KM; Park SH; Lee A; Song J; Kim HJ; Koh JT; Kim TS
Int J Cancer; 2017 May; 140(10):2364-2374. PubMed ID: 28224619
[TBL] [Abstract][Full Text] [Related]
14. Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers.
Farrington CC; Yuan E; Mazhar S; Izadmehr S; Hurst L; Allen-Petersen BL; Janghorban M; Chung E; Wolczanski G; Galsky M; Sears R; Sangodkar J; Narla G
J Biol Chem; 2020 Jan; 295(3):757-770. PubMed ID: 31822503
[TBL] [Abstract][Full Text] [Related]
15. HIF-1α downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation.
He M; Wang QY; Yin QQ; Tang J; Lu Y; Zhou CX; Duan CW; Hong DL; Tanaka T; Chen GQ; Zhao Q
Cell Death Differ; 2013 Mar; 20(3):408-18. PubMed ID: 23059786
[TBL] [Abstract][Full Text] [Related]
16. Protein Phosphatase 2a Inhibits Gastric Cancer Cell Glycolysis by Reducing MYC Signaling.
Cai Z; Zhang W; Zhou R; Wang Y; Feng Y
Cell Biochem Biophys; 2023 Mar; 81(1):59-68. PubMed ID: 36324030
[TBL] [Abstract][Full Text] [Related]
17. Cucurbitacin B induces inhibitory effects via the CIP2A/PP2A/C-KIT signaling axis in t(8;21) acute myeloid leukemia.
Ma W; Xiang Y; Yang R; Zhang T; Xu J; Wu Y; Liu X; Xiang K; Zhao H; Liu Y; Si Y
J Pharmacol Sci; 2019 Apr; 139(4):304-310. PubMed ID: 30852180
[TBL] [Abstract][Full Text] [Related]
18. TFEB links MYC signaling to epigenetic control of myeloid differentiation and acute myeloid leukemia.
Yun S; Vincelette ND; Yu X; Watson GW; Fernandez MR; Yang C; Hitosugi T; Cheng CH; Freischel AR; Zhang L; Li W; Hou H; Schaub FX; Vedder AR; Cen L; McGraw KL; Moon J; Murphy DJ; Ballabio A; Kaufmann SH; Berglund AE; Cleveland JL
Blood Cancer Discov; 2021 Mar; 2(2):162-185. PubMed ID: 33860275
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA UCA1 modulates cell proliferation and apoptosis by regulating miR-296-3p/Myc axis in acute myeloid leukemia.
Li J; Wang M; Chen X
Cell Cycle; 2020 Jun; 19(12):1454-1465. PubMed ID: 32286143
[TBL] [Abstract][Full Text] [Related]
20. Penfluridol triggers cytoprotective autophagy and cellular apoptosis through ROS induction and activation of the PP2A-modulated MAPK pathway in acute myeloid leukemia with different FLT3 statuses.
Wu SY; Wen YC; Ku CC; Yang YC; Chow JM; Yang SF; Lee WJ; Chien MH
J Biomed Sci; 2019 Aug; 26(1):63. PubMed ID: 31470848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
